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 Abstract 
 Maternal and placental conditions that are unfavourable for the embryo/foetus have long-
lasting effects on different tissues and functions of the body, which may persist for life and, 
potentially, also be transmitted to the offspring. This review resumes current evidence on 
principle maternal and gestational conditions associated with unfavourable metabolic pro-
gramming of the offspring, along with their mechanisms of action, either supposed or already 
proved.  © 2017 The Author(s)
Published by S. Karger GmbH, Freiburg 
 Introduction 
 Obesity runs in families, suggesting that genes play a role in predisposing individuals to 
obesity: having one or both parents obese, especially the mother, increases the risk of obesity 
for the offspring  [1, 2] . Twin and adoption studies have demonstrated that genes largely 
contribute to the process leading to excess fat accumulation in the body  [3, 4] . Nevertheless, 
the polygenic nature of the disease still hinders the identification of specific gene polymor-
phisms helpful in selecting subjects at a higher risk of becoming obese. In fact, recent genome-
wide analyses identified dozens of single genetic loci associated with obesity; but all these 
genes only account for a small percentage of obesity susceptibility  [5, 6] .
 Although genes predispose an individual to become obese, environmental exposition to 
obesity risk factors is necessary for the expression of the obese phenotype. The importance 
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of being exposed to an obesogenic environment is supported by the world-wide increase in 
obesity that began in the 1980s (40% in 30 years in adults), likely attributable to the rapid 
environmental and behavioural changes that occurred during this time frame more than to 
changes in genes. 
 The effects of environment begin early in life. The first environment to which the organism 
is exposed is the maternal womb. In the intra-uterine life, the organism is particularly sensitive 
to environment because of three main factors: i) the total dependency of the embryo and 
foetus on nutrients and oxygen supplies from the mother through the placental interface; ii) 
the high speed of anatomic and functional maturation of tissues and organs as well as of the 
metabolic regulation pathways; iii) the high developmental plasticity that allows tissue 
structure to adapt in response to environmental changes. This extremely sensitive status 
persists also in the first postnatal period and declines progressively with the infant’s growth 
and adaptation to the new extra-uterine environment. 
 It is now believed that epigenetic mechanisms, in which environmental factors cause 
changes in gene expression, could help to explain the observed rapid increase in obesity prev-
alence  [7] . The aim of this paper is to report the main evidence available on the relationship 
between maternal obesity as well as foetal growth and the metabolic health of the offspring.
 Developmental Programming 
 Clear evidence is available that maternal and placental conditions unfavourable for the 
embryo/foetus may have long-lasting effects on different tissues and functions of the body, 
which may persist for life and, potentially, also be transmitted to the offspring  [8, 9] . 
 The term ‘developmental programming’ defines a set of mechanisms that lead to 
permanent changes in the physiology, metabolism and epigenome of an individual, which will 
subsequently increase his disease risk, as a consequence of having been exposed to risk 
factors during prenatal or early postnatal development  [10] . These risk factors include, but 
are not limited to, maternal nutrition (under- or over-nutrition), teratogens (pollutants, 
drugs, alcohol etc.), altered hormonal milieus (resulting from maternal obesity, excess gesta-
tional weight gain, diabetes mellitus), maternal stress and oxidative stress (maternal hyper-
tension or placenta insufficiency)  [11] . The principal non-mutually exclusive mechanisms by 
which intrauterine exposures program offspring are: permanent structural changes of organs 
and tissues (pancreas, liver, skeletal muscle, adipose tissue, brain etc.), epigenetic programming 
of gene expression (by DNA methylation, histone modifications and microRNA) and accel-
erated cellular aging (by oxidative stress, inflammation and altered hormonal milieu)  [12] . 
Interestingly, transgenerational heritability of epigenetic modifications is possible through 
modification of the epigenome of germ cells of the developing foetus  [13] . 
 Prenatal and Perinatal Obesity-Sensitive Time Windows 
 Pre-Pregnancy Obesity  
 Obesity at conception is already an obesity risk factor for the offspring. Studies in animals 
demonstrated that offspring born from gametes of obese mothers and fathers, fertilized in 
vitro and implanted in lean surrogate dams, have a high risk of developing obesity and insulin 
resistance in adult life  [14] . Moreover, the effect of male and female gametes was additive in 
female but not in male offspring. Males had the highest risk of developing obesity if born from 
maternal gametes of obese mothers independent of obese or nonobese father gametes. 
Therefore, offspring of obese mothers, regardless of intrauterine life exposition to maternal 
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obesity, have a higher risk of developing obesity than offspring of obese fathers. In humans, 
maternal gastrointestinal bypass surgery was able to prevent transmission of obesity to 
children born after surgery compared with children born from the same mother before 
surgery  [15] . All these findings may be explained by epigenetic mechanisms.
 Gestational Weight Gain  
 Excessive gestational weight gain is associated with an obesity risk in childhood  [16] . The 
risk is high for a high weight gain in the first trimester of pregnancy (22% of risk increase per 
200 g/week of excessive gestational weight gain)  [17] . In the second and third trimester of 
pregnancy, excessive weight gain is associated with a higher risk of bearing large-for-gesta-
tional-age neonates but not with child anthropometry at later ages. Interestingly, maternal 
weight gain and increased BMI between pregnancies increases the risk of overweight in 
offspring compared with their siblings  [18] .  
 Studies in animals have shown that maternal over-nutrition during pregnancy, both 
high-fat and high-calorie diets, increases adiposity and inflammation in the offspring  [19] . 
Moreover, the offspring of dams exposed to a high-fat diet during pregnancy maintained an 
adverse metabolic profile and epigenetic changes through adulthood  [20] . The mechanisms 
linking maternal malnutrition and excessive weight in pregnancy to later-life metabolic 
health of the offspring are unclear. Some evidence is available on the association between 
maternal diet and reduced leptin or insulin sensitivity as well as reduction of sympathetic 
activity within the adipose tissue of the offspring  [21–23] . Leptin, insulin, glucocorticoids and 
ghrelin are involved in metabolic programming mechanisms at both central (CNS) and 
peripheral levels (adipose tissue, liver, skeletal muscle)  [21, 22, 24] . 
 Body Fat and Metabolic Changes in Pregnancy 
 Normal-weight and obese women tend to gain a similar amount of fat during pregnancy. 
However, lean women accumulate fat in the peripheral body compartments, whereas obese 
women store fat mainly in the abdominal area, with accumulation of fat also in the liver and 
placenta  [25] . 
 Body fat distribution in obese women favours lipotoxicity and metabolic dysfunctions, 
leading to foetal exposition to glucose and fat overload that promotes an increase in foetal 
size and fat mass as well as metabolic dysfunction and inflammation, which favours altered 
metabolic programming. 
 Glucose metabolism in pregnancy is characterized by increased insulin secretion in the 
first two trimesters, which promotes maternal body fat accumulation, and by insulin resis-
tance in the last trimester, favouring a substrate supply to the foetus to satisfy the increased 
demand. The foetus uses more than 50% of the total maternal glucose turnover, which mainly 
depends on increased maternal hepatic gluconeogenesis. This process is exaggerated in 
pregnant women with obesity and/or diabetes, leading to glucose and lipid overload in the 
foetus. Dysfunctional maternal glucose metabolism in pregnancy is associated with the risk 
of obesity in the offspring. In particular, among women with gestational diabetes, maternal 
fasting plasma glucose during pregnancy was associated with birth size and the risk of obesity 
at the age of 7 years in their children, adjusting for pre-pregnancy BMI  [26] . Exposure to intra-
uterine hyperglycaemia was associated with impaired insulin sensitivity and relatively 
impaired insulin secretion in adulthood, both of which are characteristics of type 2 diabetes 
 [27] . 
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 Pregnancy, Microbiome and Risk of Obesity in Offspring 
 Mothers share their microbes and microbiome metabolites with the foetus during 
delivery and during lactation. However, it has recently been suggested that the womb may 
not be sterile and microbial exposure may begin in utero, so the placenta and amniotic fluid 
may be potential sources of intrauterine microbial transmission from the mother to the devel-
oping foetus  [28] . Maternal diet, health status, metabolism, mode of delivery, gestational 
weight gain, genetics and use of antibiotics affect microbiome composition  [29] . 
 The maternal gut microbiota is different in normal-weight and obese pregnant women, 
particularly in the second half of pregnancy. Obese women showed an increase in Firmicutes 
phylum ( Staphylococcus ) and some Proteobacteria ( Escherichia coli )  [30] . Maternal microbes 
may affect the developing foetus through several mechanisms  [31] . One of these is foetal 
exposition to elevated levels of microbe-derived plasma endotoxin, which may increase gut 
translocation of bacteria-derived products across the intestinal mucosa, contributing to 
systemic and placental inflammation and insulin resistance. Another possible consequence 
of nutrient-gut microbiota interaction is increased acetate production. This, by subsequent 
parasympathetic activation, has been shown to increase glucose-stimulated insulin secretion, 
ghrelin secretion, food intake and obesity in rats  [32] . Indeed, further studies are necessary 
to confirm these interesting and stimulating preliminary findings. 
 From a clinical point of view, manipulation of microbiota by diet, antibiotics, pre-, pro- or 
synbiotics could potentially contribute to reduce the risk of developing obesity, especially if 
applied in specific high-sensitive windows, like pregnancy and early infancy. However, further 
experience must be accumulated in order to define the efficacy and safety of this approach for 
preventing obesity. 
 Prevention of Maternal Obesity-Related Health Consequences for the Offspring 
 Guidelines to prevent the offspring from developing negative health consequences asso-
ciated with maternal obesity or with excessive gestational weight gain, have been available 
since 1990, have been revised in 2009  [33] and have been recently acknowledged by the 
European College of Obstetrics and Gynaecology  [34] . These guidelines clearly state that 
obese women should try to lose weight and improve their lifestyle before conceiving and that 
different ranges of ideal gestational weight gain should be pursued by pregnant women 
according to their pregestational weight status  [33] . In particular, while normal-weight 
women should gain 25–35 lbs (11.25–15.75 kg), overweight and obese ones should gain 
15–25 lbs (6.75–11.25 kg) and 11–20 lbs (4.95–9.00 kg) respectively  [33] . This objective 
should be achieved with the help of nutritional and lifestyle counselling from health profes-
sionals in charge of the follow-up of pregnant women  [33] . Unfortunately, according to recent 
epidemiological data from the US, since the publication of the guidelines in 1990 no reduction 
in gestational weight gain among overweight/obese women relative to normal-weight/
underweight women and no changes in gestational weight gain by pre-pregnancy BMI for 
either overweight/obese or normal-weight/underweight women have occurred  [35] . 
Moreover, randomized controlled trials targeting obese pregnant women failed to reduce 
their gestational weight gain  [36] . Thus, the ideal weight management in obese pregnant 
women remains to be determined, and effective policies targeting maternal and child health 
via lifestyle and dietary behaviours are lacking  [33–36] .
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 Conclusions 
 Maternal obesity is a proven obesity risk factor for the offspring. The progressive trend 
of increasing obesity prevalence among pregnant women is alarming and suggests the need 
for further efforts in public health intervention for obesity control. 
 Available evidence strongly supports the rationale to begin obesity prevention as soon 
as possible. In particular, the crucial role of the mother suggests starting intervention before 
pregnancy and to continue prevention both during and after pregnancy. 
 At present, an adequate diet and physical activity before and during pregnancy as well as 
control of gestational weight gain and blood glucose are mandatory procedures to reduce the 
risk of obesity in offspring. 
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